Addex to Attend 38th Annual J.P. Morgan Healthcare Conference

Addex to Receive Additional $800K Funding from Indivior for GABAB PAM Addiction Program

ADDEX THERAPEUTICS PUBLICLY FILES REGISTRATION STATEMENT WITH THE U.S. SEC TO FACILITATE NASDAQ LISTING OF ADSs REPRESENTING SHARES

Addex: Van Leeuwenhoeck Issues Update Equity Research Report

Addex to Attend Jefferies 2019 London Healthcare Conference

Addex to Present at 25th Annual BIO-Europe Conference in Hamburg

Addex to Receive Additional Funding from Indivior for GABAB PAM Addiction Program

Addex Reports 2019 Half-Year Financial Results and Provides Corporate Update

ADDEX THERAPEUTICS TO RELEASE HALF-YEAR 2019 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON SEPTEMBER 30, 2019

ADDEX THERAPEUTICS SUBMITS REGISTRATION STATEMENT WITH THE U.S. SEC TO FACILITATE NASDAQ LISTING OF ADSS REPRESENTING SHARES